EFFECT OF SYSTEMIC LUPUS ERYTHMATOSUS IN MINORITIES
系统性红斑狼疮对少数族裔的影响
基本信息
- 批准号:7380394
- 负责人:
- 金额:$ 3.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2007-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this project is to study the inter-relationship between demographic, socioeconomic, and genetic factors in determining the course and early outcome in patients with systemic lupus erythematosus (SLE). This study has centers in Houston and Galveston, Texas as well in Puerto Rico, which in addition to following African-American and Caucasian patients with SLE, follows Hispanic patients at 2 different locations: Texas and Puerto Rico. An added dimension of the LUMINA study is the PROFILE sub-study. PROFILE is Project 4 of the PO1 Program Project in the genetics of SLE at UAB. Its goal is to determine the role that genetics plays in the outcome of lupus. As such, not only is patient DNA obtained to investigate genes related to SLE, but parents and siblings are being recruited (TRIO families) so that their DNA may be analyzed as well. Results to date indicate that Hispanic and African-American patients have more active SLE, at an earlier age of onset, and a less favorable socioeconomic-demographic structure (worse among Hispanics than African-American), which predispose them to a less favorable natural history. [Alarc¿n, 1999]
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。本研究旨在探讨系统性红斑狼疮(SLE)患者的病程和早期预后与人口统计学、社会经济学和遗传因素之间的相互关系。本研究在休斯顿和加尔维斯顿,德克萨斯州以及波多黎各设有研究中心,除了随访非裔美国人和白人SLE患者外,还随访了2个不同地点的西班牙裔患者:德克萨斯州和波多黎各。 LUMINA研究的另一个维度是PROFILE子研究。PROFILE是UAB SLE遗传学PO 1项目的项目4。它的目标是确定遗传学在狼疮结果中所起的作用。因此,不仅获得患者DNA以研究与SLE相关的基因,还招募父母和兄弟姐妹(TRIO家族),以便也可以分析他们的DNA。 迄今为止的结果表明,西班牙裔和非洲裔美国人患者有更多的活动性SLE,在较早的发病年龄,和一个不太有利的社会经济人口结构(西班牙裔比非洲裔美国人更差),这使他们倾向于一个不太有利的自然史。[阿拉尔,1999年]
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Graciela S Alarcon其他文献
Graciela S Alarcon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Graciela S Alarcon', 18)}}的其他基金
EFFECT OF SYSTEMIC LUPUS ERYTHMATOSUS IN MINORITIES
系统性红斑狼疮对少数族裔的影响
- 批准号:
7603162 - 财政年份:2007
- 资助金额:
$ 3.03万 - 项目类别:
ACR RE-CLASSIFICATION OF SLE CRITERIA (AROSE) ORIG GRANT REVISION OF ACR CLASSIF
ACR SLE 标准重新分类 (AROSE) 原始拨款修订 ACR 分类
- 批准号:
7380477 - 财政年份:2006
- 资助金额:
$ 3.03万 - 项目类别:
EFFECT OF SYSTEMIC LUPUS ERYTHMATOSUS IN MINORITIES
系统性红斑狼疮对少数族裔的影响
- 批准号:
7198514 - 财政年份:2005
- 资助金额:
$ 3.03万 - 项目类别:
Effect of systemic lupus erythmatosus in minorities
系统性红斑狼疮对少数族裔的影响
- 批准号:
6980477 - 财政年份:2004
- 资助金额:
$ 3.03万 - 项目类别:
MODIFIABLE RISK FACTORS FOR ADVERSE OUTCOMES IN SLE
SLE 不良后果的可改变风险因素
- 批准号:
6565383 - 财政年份:2001
- 资助金额:
$ 3.03万 - 项目类别:
GENETIC RISK PROFILE IN LONGITUDINAL SLE COHORTS
纵向 SLE 队列中的遗传风险概况
- 批准号:
6493284 - 财政年份:2001
- 资助金额:
$ 3.03万 - 项目类别:
MODIFIABLE RISK FACTORS FOR ADVERSE OUTCOMES IN SLE
SLE 不良后果的可改变风险因素
- 批准号:
6410699 - 财政年份:2000
- 资助金额:
$ 3.03万 - 项目类别:
GENETIC RISK PROFILE IN LONGITUDINAL SLE COHORTS
纵向 SLE 队列中的遗传风险概况
- 批准号:
6348946 - 财政年份:2000
- 资助金额:
$ 3.03万 - 项目类别:
MODIFIABLE RISK FACTORS FOR ADVERSE OUTCOMES IN SLE
SLE 不良后果的可改变风险因素
- 批准号:
6302993 - 财政年份:1999
- 资助金额:
$ 3.03万 - 项目类别:
GENETIC RISK PROFILE IN LONGITUDINAL SLE COHORTS
纵向 SLE 队列中的遗传风险概况
- 批准号:
6201555 - 财政年份:1999
- 资助金额:
$ 3.03万 - 项目类别:
相似海外基金
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
Allogeneic BAFF Ligand Based CAR T-Cells as a Novel Therapy for Systemic Lupus Erythematous
基于同种异体 BAFF 配体的 CAR T 细胞作为系统性红斑狼疮的新疗法
- 批准号:
10761003 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
Role of thymidylate synthetase in B cells of systemic lupus erythematosus
胸苷酸合成酶在系统性红斑狼疮B细胞中的作用
- 批准号:
23K07893 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Splenic Modulation of SHP-2 Activity as a Therapeutic Option for Systemic Lupus Erythematosus
脾脏调节 SHP-2 活性作为系统性红斑狼疮的治疗选择
- 批准号:
10668102 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
Physical Activity Behaviors and Readiness for a Digital Health Physical Activity Intervention inOlder Adults with Systemic Lupus Erythematosus
患有系统性红斑狼疮的老年人的身体活动行为和数字健康身体活动干预的准备
- 批准号:
10726230 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
PREVENT-SLE: Towards PREdiction and preVENTion of Systemic Lupus Erythematosus
PREVENT-SLE:系统性红斑狼疮的预测和预防
- 批准号:
EP/Y023560/1 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
Research Grant
The Impact of Obesity and Leptin on the Development of Immune System Dysfunction and Hypertension in Females with Systemic Lupus Erythematous
肥胖和瘦素对女性系统性红斑狼疮免疫系统功能障碍和高血压的影响
- 批准号:
10714532 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
Interaction between chronic inflammation, pain, and brain function in systemic lupus erythematosus
系统性红斑狼疮慢性炎症、疼痛和脑功能之间的相互作用
- 批准号:
23K07903 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Systemic Lupus Erythematosus
开发一种新型核苷挽救途径靶向小分子抑制剂来治疗系统性红斑狼疮
- 批准号:
10755905 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别:
Engineered DNA-particles to model immune events in systemic lupus erythematosus
工程 DNA 颗粒模拟系统性红斑狼疮的免疫事件
- 批准号:
10644574 - 财政年份:2023
- 资助金额:
$ 3.03万 - 项目类别: